Biosimilar Newsletter Archive
-
02.03.22 -- Congressional Bill Bolsters Continuous Manufacturing
2/3/2022
02/03/22 Biosimilar Development Newsletter
-
01.31.22 -- Managing The Biomanufacturing Supply Chain
1/31/2022
01/31/22 Biosimilar Development Newsletter
-
01.28.22 -- Enabling An Improved Patient Experience Through Innovative Solutions
1/28/2022
01/28/22 Biosimilar Development Newsletter
-
01.27.22 -- 2021's Bioprocessing Year In Review
1/27/2022
01/27/22 Biosimilar Development Newsletter
-
01.20.22 -- Data Integrity: New & Pending Guidances
1/20/2022
01/20/22 Biosimilar Development Newsletter
-
01.19.22 -- Bioprocess Automation To Help Enhance Efficiency And Operations
1/19/2022
01/19/22 Biosimilar Development Newsletter
-
01.13.22 -- Listen Now: CAR T Manufacturing Control, Genome Engineering of Hematopoietic Stem Cells, and more!
1/13/2022
01/13/22 Biosimilar Development Newsletter
-
01.13.22 -- How EU Biopharma Can Blaze The IDMP Data Standards Trail
1/13/2022
01/13/22 Biosimilar Development Newsletter
-
01.06.22 -- Bioprocess Facility Design: Layout Rules & Configurations
1/6/2022
01/06/22 Biosimilar Development Newsletter
-
12.23.21 -- Regulatory Intelligence: It's More Than Just Compliance
12/23/2021
12/23/21 Biosimilar Development Newsletter
This website uses cookies to ensure you get the best experience on our website. Learn more